The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration

The treatment of liver fibrosis has clinical limitations because of its multiple etiologies, such as epithelial–mesenchymal transition (EMT) promotion, cell regeneration and remodeling dysfunction, inflammatory cell activation, and scar tissue deposition. These factors might be considered as a new t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Pharmacol
Päätekijät: Chuang, Hong-Meng, Su, Hong-Lin, Li, Chien, Lin, Shinn-Zong, Yen, Ssu-Yin, Huang, Mao-Hsuan, Ho, Li-Ing, Chiou, Tzyy-Wen, Harn, Horng-Jyh
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2016
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847481/
https://ncbi.nlm.nih.gov/pubmed/27199755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00112
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia